Population Screening Act: Rotterdam Study expanded to include liver and skin screening

In this advisory report, the Committee on the Population Screening Act discusses the assessment of an application for authorisation submitted by the Erasmus Medical Centre in Rotterdam. The application concerns two sub-studies within the Erasmus Rotterdam Health Study (ERGO, also called ‘Rotterdam Study’): one related to liver disorders and the other related to skin conditions. The Minister of Health, Welfare and Sport requested an advisory report from the Health Council of the Netherlands within the scope of the Population Screening Act.